EUVIMEDEUVIMED entdecken
Crossref

Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy

Shinnosuke Kawahara, Toru Aoyama, Itaru Hashimoto, Rei Kanemoto, Naohiko Matsushita, Mariko Kamiya, Yosuke Atsumi, Yukio Maezawa, Keisuke Kazama, Masaaki Murakawa, Satoshi Kobayashi, Makoto Ueno und 5 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Shinnosuke Kawahara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan; kusoshin.0714@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tegafur, Neoadjuvant Therapy, Oxonic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Although perioperative chemotherapy has improved patient survival, sarcopenia may occur during chemotherapy owing to decreased food intake and physical strength. However, reports on the occurrence of sarcopenia and changes in body composition in patients with pancreatic cancer during neoadjuvant chemotherapy are scarce. This study aimed to determine the effect of changes in skeletal muscle mass during neoadjuvant chemotherapy on the S-1 adjuvant chemotherapy clinical course in patients who underwent perioperative chemotherapy and surgical resection. PATIENTS AND METHODS: We retrospectively enrolled 159 patients with pancreatic cancer who underwent neoadjuvant chemotherapy and surgical resection, followed by S-1 adjuvant chemotherapy. We evaluated changes in skeletal muscle mass during neoadjuvant chemotherapy using abdominal computed tomography and the SliceOmatic software. The association between the rate of change in skeletal muscle mass index (Δ%SMI) during neoadjuvant chemotherapy and the continuation of S-1 adjuvant chemotherapy was investigated. RESULTS: Eighty-eight (55.3%) patients lost skeletal muscle mass (Δ%SMI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsTegafurNeoadjuvant TherapyOxonic AcidDrug CombinationsMuscle, SkeletalPancreatectomySarcopeniaHumansMaleFemaleChemotherapy, AdjuvantMiddle AgedAgedRetrospective StudiesAntimetabolites, AntineoplasticAdult

Stichwörter der Autor:innen

Pancreatic cancerS-1SMIcontinuationneoadjuvant chemotherapyrisk factorskeletal muscle mass

Substanzen

TegafurS 1 (combination)Oxonic AcidDrug CombinationsAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan; kusoshin.0714@gmail.com.
  • Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Department of Gastroenterology, Kanagawa Cancer Center, Kanagawa, Japan.

Zitieren

APA

Kawahara, S., Aoyama, T., Hashimoto, I., Kanemoto, R., Matsushita, N., Kamiya, M., Atsumi, Y., Maezawa, Y., Kazama, K., Murakawa, M., Kobayashi, S., Ueno, M., Yamamoto, N., Oshima, T., Yukawa, N., Saito, A., & Morinaga, S. (2024). Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy. Anticancer Research. https://doi.org/10.21873/anticanres.17286

Vancouver

Kawahara S, Aoyama T, Hashimoto I, Kanemoto R, Matsushita N, Kamiya M, et al. Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy. Anticancer Research. 2024. doi:10.21873/anticanres.17286

BibTeX
@article{Kawahara2024,
  author = {Kawahara, Shinnosuke and Aoyama, Toru and Hashimoto, Itaru and Kanemoto, Rei and Matsushita, Naohiko and Kamiya, Mariko and Atsumi, Yosuke and Maezawa, Yukio and Kazama, Keisuke and Murakawa, Masaaki and Kobayashi, Satoshi and Ueno, Makoto and Yamamoto, Naoto and Oshima, Takashi and Yukawa, Norio and Saito, Aya and Morinaga, Soichiro},
  title = {Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17286}
}
Kostenlos starten →